Visual Performance of Clareon Vivity and PureSee IOL

Sponsor
OMIQ Research
Study ID
NCT07165197
Status
Recruiting
Apply to this trial

Conditions

  • Cataract

Eligibility Criteria

Sex
ALL
Age
50 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Phacoemulsification with implantation of an extended depth of focus intraocular lens — DEVICE
    Comparison of two different Extended depth of focus intraocular lenses

Study Details

This is study to determine the visual performance of patients with age-related cataracts implanted in both eyes with either of two extended depth of focus intraocular lenses, the Clareon Vivity (Alcon Healthcare) or the PureSee (Johnson \& Johnson)

Key Dates

First listed
Sep 10, 2025
Start date
Jun 27, 2025
Status verified
Sep 2025
Primary completion
Mar 31, 2026
Completion
Mar 31, 2026

Study Design

Enrollment
80 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Extended depth of focus intraocular lens Clareon Vivity
  • Active Comparator: Extended depth of focus intraocular lens PureSee

Primary Outcome Measure

Distance-corrected binocular defocus curve at 4 m [ Time Frame: 3 months ]

Related Studies